The purpose of this research study is to evaluate the safety and efficacy of pramipexole extended release (ER) versus escitalopram for the treatment of major depressive disorder (MDD) and mild neurocognitive disorder (MND) in people living with HIV (PWH). This study will also look at whether you experience any side effects from the study drugs.
Thank you for your interest, but this study is recruiting by invitation only.
International (Vietnam)
Vivian Go
Health Behavior
Clinical or Medical
Interventional
HIV/AIDS
Mental and Emotional Health
25-0608
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
